Lipitor Lawsuit Filings Surpass 1,300 Cases in Federal Diabetes Litigation, Bernstein Liebhard LLP R

The Firm is evaluating potential Lipitor lawsuits on behalf of individuals who developed new-onset Type 2 diabetes, allegedly due to their use of the statin medication. New York, New York (PRWEB) October 27, 2014 The number of Lipitor lawsuits (http://www.lipitorlawsuitcenter.com/) that allege the statin medication increases the risk for new-onset Type 2 diabetes continues to mount in the federal multidistrict litigation currently underway in U.S. District Court, District of South Carolina, Bernstein Liebhard LLP reports. According to an updated Docket Report issued by the U.S. Judicial Pa
Contributor
PR Web
PR Web
Lanham, Maryland
Law Marketing
1.800.345.5572
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Download

Related Documents in PR Web
MCLE Sales

Categories